文献速递鼻科

鼻后神经冷冻消融治疗慢性鼻炎的流涕反应预测因素

Predictors of rhinorrhea response after posterior nasal nerve cryoablation for chronic rhinitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2020-05-22

这项多中心回顾性病例对照研究纳入55例接受鼻后神经冷冻消融的慢性鼻炎患者,术前进行1个月异丙托溴铵鼻喷剂试验。结果显示,仅异丙托溴铵反应可预测冷冻消融后流涕改善(反应者85%改善 vs 无反应者33%,p=0.001)。

要点

  • 异丙托溴铵鼻喷剂反应可预测鼻后神经冷冻消融后流涕改善。
  • 反应者术后流涕评分改善率85%,无反应者仅33%。
  • 术前异丙托溴铵试验有助于患者咨询和预期管理。

核心结论

  • 慢性鼻炎患者对异丙托溴铵的流涕反应可预测鼻后神经冷冻消融后的流涕改善。

研究设计与样本

  • 多机构回顾性病例对照研究,纳入55例因过敏性、非过敏性或以混合性鼻炎导致双侧流涕并接受鼻后神经冷冻消融的患者,来自3个三级医疗中心。

主要发现

  • 48例尝试异丙托溴铵鼻喷剂的患者中,33例(69%)有某种反应,15例(31%)无反应。
  • 鼻后神经冷冻消融后,39例(71%)流涕评分(RNS)下降≥1分。
  • 异丙托溴铵反应者中28/33(85%)术后RNS改善,无反应者中5/15(33%)改善(p=0.001)。

关键数值与推荐

  • 平均年龄55.3岁,女性占54.6%,平均随访170天,非过敏性鼻炎占62%。
  • 术前平均总体RNS为4.2 ± 1.0。
  • 仅异丙托溴铵鼻喷剂反应预测冷冻消融成功。

临床怎么用

  • 术前可用异丙托溴铵鼻喷剂试验辅助筛选可能从鼻后神经冷冻消融获益的患者。
  • 对异丙托溴铵无反应者,应告知其术后流涕改善的可能性较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Posterior nasal nerve (PNN) cryoablation has shown promise in improving rhinorrhea due to allergic and nonallergic rhinitis (NAR). Early case series have shown meaningful clinical improvement in 75-80% of patients, but variables predicting PNN cryoablation success have not been studied. The purpose of this study was to evaluate whether disease features and ipratropium nasal spray response predicted rhinorrhea response after PNN cryoablation. METHODS: A multi-institutional retrospective case-control study of 55 patients who underwent PNN cryoablation for bilateral rhinorrhea due to allergic, nonallergic, or mixed rhinitis was conducted at 3 tertiary medical centers. Patients received a 1-month trial of ipratropium spray. Runny Nose Scores (RNSs) of 0-5 from the 22-item Sino-Nasal Outcome Test were collected prospectively, before and after PNN cryoablation. RESULTS: The mean age of subjects was 55.3 years and 54.6% were women. Mean follow-up was 170 days. NAR comprised 62% of patients. Of the 48 patients who trialed ipratropium spray, 33 (69%) had some response and 15 (31%) had no response. Mean overall preprocedural RNS was 4.2 ± 1.0. After PNN cryoablation, there was a ≥1-point decrease in RNS in 39 patients (71%). Only ipratropium spray (INS) response predicted cryoablation success. For ipratropium spray responders, 28 of 33 (85%) had improved RNS after cryoablation, whereas 5 of 15 (33%) nonresponders improved (p = 0.001). CONCLUSION: In chronic rhinitis patients, rhinorrhea response to ipratropium was predictive of rhinorrhea improvement after PNN cryoablation. This study has important implications for preoperative counseling and guiding patient expectations when considering PNN cryoablation.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Yoo F, Kuan EC, Batra PS, et al. Predictors of rhinorrhea response after posterior nasal nerve cryoablation for chronic rhinitis. Int Forum Allergy Rhinol. 2020. PMID: 32445248. doi:10.1002/alr.22574

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。